Results 11 to 20 of about 13,265 (250)
Management of Barrett’s Esophagus [PDF]
Canadian Journal of Gastroenterology, 2000 There have been major recent advances in the understanding of the pathogenesis and epidemiology of Barrett’s esophagus and adenocarcinoma of the esophagus.
Ziad Younes +2 more
doaj +4 more sources
Artificial Intelligence-assisted Endoscopy and Examiner Confidence: A Study on Human-Artificial Intelligence Interaction in Barrett's Esophagus (With Video). [PDF]
DEN OpenABSTRACT Objective Despite high stand‐alone performance, studies demonstrate that artificial intelligence (AI)‐supported endoscopic diagnostics often fall short in clinical applications due to human‐AI interaction factors. This video‐based trial on Barrett's esophagus aimed to investigate how examiner behavior, their levels of confidence, and system ...
Roser D +13 more
europepmc +2 more sources
Mayo Clinic Proceedings, 2019 Barrett esophagus is a metaplastic change in the lining of the distal esophageal epithelium, characterized by replacement of the normal squamous epithelium by specialized intestinal metaplasia. The presence of Barrett esophagus increases the risk of esophageal adenocarcinoma several-fold.
Prasad G. Iyer, Vivek Kaul
openaire +2 more sources
Gastroenterology Clinics of North America, 2008 Barrett's esophagus is an important step in the pathway to esophageal adenocarcinoma. Since most patients with Barrett's esophagus are undiagnosed and patients present with advanced adenocarcinoma de novo, prognosis for this disease remains poor. To identify those people with Barrett's esophagus who are at particular risk many new technologies are ...
Bird-Lieberman, E, Fitzgerald, R
openaire +3 more sources
Chest Surgery Clinics of North America, 1994 The development of the columnar-lined lower esophagus, or Barrett's disease, is an acquired condition due to reflux of gastric and duodenal contents. The medical treatment of patients with reflux disease and Barrett's esophagus is currently the same as for patients with reflux without Barrett's disease which may indicate more aggressive antireflux ...
M, Pera, V F, Trastek
openaire +4 more sources
Molecular Cancer, 2006 Background Barrett's esophagus, a risk factor for esophageal adenocarcinoma, is associated with reflux disease. The aim of this study was to assess the expression of bile acid receptors in the esophagus (normal, esophagitis, Barrett's esophagus and ...
Frossard Jean-Louis +10 more
doaj +1 more source
Review: Diagnosis and management of Barrett’s esophagus for the endoscopist
Therapeutic Advances in Gastroenterology, 2010 In Barrett’s esophagus, the stratified squamous epithelium lining the esophagus is replaced by specialized intestinal-type columnar epithelium. The prevalence of Barrett’s esophagus has ranged from 0.9% to 4.5%.
Sagar S. Garud +3 more
doaj +1 more source
Barrett's esophagus: Ten years of experience at a tertiary care hospital center in Mexico
Revista de Gastroenterología de México (English Edition), 2018 Introduction: The prevalence of Barrett's esophagus has been calculated at between 1.3 and 1.6%. There is little information with respect to this in Mexico.
F. Valdovinos-Andraca +7 more
doaj +1 more source
The Oxidative Damage and Inflammation Mechanisms in GERD-Induced Barrett’s Esophagus
Frontiers in Cell and Developmental Biology, 2022 Barrett’s esophagus is a major complication of gastro-esophageal reflux disease and an important precursor lesion for the development of Barrett’s metaplasia and esophageal adenocarcinoma.
Deqiang Han, Deqiang Han, Chao Zhang
doaj +1 more source
DINAMIC SCREENING OF PRECANCEROUS ESOPHAGUS USING MOLECULAR GENETIC ANALYSIS
Сибирский онкологический журнал, 2020 Introduction. Esophageal adenocarcinoma develops from areas of intestinal metaplasia in Barrett’s esophagus, similar to how intestinal metaplasia transforms into gastric adenocarcinomas in the stomach.
V. V. Anishchenko +5 more
doaj +1 more source